|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1747 USD | -5.21% |
|
+28.88% | -12.39% |
| 05-15 | Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform | CI |
| 05-09 | Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M | MT |
Zomedica Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 18.93 million compared to USD 4.13 million a year ago.
Net loss was USD 17.02 million compared to USD 18.38 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.39% | 181M | |
| -40.11% | 938M |
ZOMEDICA CORP. 
